Compare AMRX & IEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | IEP |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 2018 | 1994 |
| Metric | AMRX | IEP |
|---|---|---|
| Price | $18.68 | $7.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.60 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 639.8K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 24.39% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | ★ $9,658,000,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.13 | $5.02 |
| P/E Ratio | $95.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.67 | $7.08 |
| 52 Week High | $18.39 | $9.52 |
| Indicator | AMRX | IEP |
|---|---|---|
| Relative Strength Index (RSI) | 70.49 | 68.61 |
| Support Level | $12.46 | $7.55 |
| Resistance Level | N/A | $8.27 |
| Average True Range (ATR) | 0.56 | 0.13 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 96.30 | 96.49 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.